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Association of maternal vitamin D status during pregnancy 
with bone-mineral content in oﬀ spring: a prospective 
cohort study
Debbie A Lawlor, Andrew K Wills, Abigail Fraser, Adrian Sayers, William D Fraser, Jonathan H Tobias
Summary
Background Maternal vitamin D status in pregnancy is a suggested determinant of bone-mineral content (BMC) in 
oﬀ spring, but has been assessed in small studies. We investigated this association in a large prospective study.
Methods Eligible participants were mother-and-singleton-oﬀ spring pairs who had participated in the Avon Longitudinal 
Study of Parents and Children, and in which the mother had recorded measurements of 25(OH)D concentration in 
pregnancy and the oﬀ spring had undergone dual-energy x-ray absorptiometry at age 9–10 years. 25(OH)D 
concentrations in pregnancy were assessed per 10·0 nmol/L and classiﬁ ed as suﬃ  cient (more than 50·00 nmol/L), 
insuﬃ  cient (49·99–27·50 nmol/L), or deﬁ cient (lower than 27·50 nmol/L). Associations between maternal serum 
25(OH)D concentrations and oﬀ spring total body less head (TBLH) and spinal BMC were assessed by trimester.
Results 3960 mother-and-oﬀ spring pairs, mainly of white European origin, were assessed (TBLH BMC n=3960, spinal 
BMC n=3196). Mean oﬀ spring age was 9·9 years. 2644 (67%) mothers had suﬃ  cient, 1096 (28%) insuﬃ  cient, and 
220 (6%) deﬁ cient 25(OH)D concentrations in pregnancy, but TBLH and spinal BMC did not diﬀ er between oﬀ spring 
of mothers in the lower two groups versus suﬃ  cient 25(OH)D concentration. No associations with oﬀ spring BMC 
were found for any trimester, including the third trimester, which is thought to be most relevant (TBLH BMC 
confounder-adjusted mean diﬀ erence –0·03 g per 10·0 nmol/L, 95% CI –1·71 to 1·65; spinal BMC 0·04 g per 
10·0 nmol/L, 95% CI –0·12 to 0·21).
Conclusions We found no relevant association between maternal vitamin D status in pregnancy and oﬀ spring BMC in 
late childhood.
Funding UK Medical Research Council, Wellcome Trust, and University of Bristol.
Introduction
Vitamin D is essential for the maintenance of calcium 
homoeostasis and regulation of bone mineralisation.1 
Deﬁ ciency in children can lead to rickets, and in adults it 
is related to osteomalacia, osteoporosis, and risk of 
fractures.2,3 Lowered concentrations of vitamin D during 
pregnancy are suggested to be related to low bone-
mineral content (BMC) in oﬀ spring.4 If this association 
is true, it is relevant to public health, as up to 70% of 
otherwise healthy pregnant women have insuﬃ  cient 
concentrations (most commonly deﬁ ned as lower 
than 50·0 nmol/L) of 25-hydroxyvitamin D (25[OH]D).5,6 
This association has been assessed in three small 
(fewer than 200 participants) studies. One suggested a 
nega tive association (low maternal 25[OH]D but high 
oﬀ spring BMC),7 another a positive association,4 and a 
third a null association.8
We did a large prospective study to investigate whether 
there is an association between maternal 25(OH)D 
concentrations in pregnancy and oﬀ spring BMC. We 
also aimed to assess whether the association is mediated 
by the child’s own 25(OH)D concentration, which relates 
directly to BMC.9 Additionally, we tested the hypothesis 
that the third trimester is a sensitive period for bone 
mineralisation by 25(OH)D.4,10,11
Methods
Participants
The Avon Longitudinal Study of Parents and Children 
(ALSPAC) is a prospective population-based study that 
recruited a cohort of 14 541 pregnant women resident in 
southwest England with delivery expected between 
April 1, 1991, and Dec 31, 1992.12,13 13 678 singleton live-
born infants resulted from these pregnancies. For this 
study, eligible participants were mother-and-singleton-
oﬀ  spring pairs in which the mother had valid results for 
25(OH)D concentrations in preg nancy and oﬀ spring had 
undergone dual-energy x-ray absorptiometry (DXA) at 
age 9–10 years. We obtained ethics approval for this study 
from the ALSPAC law and ethics committee and the 
local National Health Service research ethics committee. 
Participants provided written informed consent.
Measurement of vitamin D concentrations and 
bone-mineral content
Maternal non-fasting blood samples taken as part of 
routine antenatal care were collected and stored initially 
at –20°C, and then at –80°C, with no further freeze–thaw 
cycles, until the time of 25(OH)D measurement. Serum 
samples could be from any stage of pregnancy. If a 
woman had more than one result, we used the latest. The 
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dates of blood sampling were obtained from medical 
records and veriﬁ ed from the freezer storage data to 
enable calculation of gestational age at the time of 
maternal 25(OH)D measurement and adjustment for 
seasonality. Serum samples from oﬀ spring obtained 
during the clinic visit at age 9–10 years were also assessed. 
Serum 25(OH)D concentrations for mothers and oﬀ -
spring were measured with high-per formance liquid 
chromatography tandem mass spec trometry with an 
internal standard (appendix p 1),9,14 in one laboratory, in 
accordance with the performance target set by the 
Vitamin D External Quality Assessment Scheme advisory 
panel. We calculated 25(OH)D concentrations in each 
trimester of pregnancy and overall. We also calculated a 
measure of 25(OH)D that was adjusted for seasonality 
(appendix pp 1–3).
DXA scans were obtained with a Lunar Prodigy scanner 
(GE Healthcare, London, UK), as described elsewhere.15 
We used mean diﬀ erences (per 10·0 nmol/L or per 
category of 25[OH]D) in total body less head (TBLH) and 
spinal BMC as our primary outcomes because maternal 
pregnancy 25(OH)D concentration is hypothesised to 
aﬀ ect BMC. We also investigated associations with bone-
mineral density, bone area (with and without adjustment 
for height), and bone-area-adjusted BMC (appendix p 1).
Statistical analysis
We used medians (IQRs) and proportions to describe 
all variables for included mothers and oﬀ spring, and 
for those excluded because of missing data (maternal 
25(OH)D concentration or oﬀ spring BMC results). 
Diﬀ erences between included mother-and-oﬀ spring 
pairs and those excluded because of missing data were 
investigated with t tests for continuously measured 
variables (with those variables that were right-skewed 
being logged) and χ² tests for categorical variables. 
Pearson’s correlation coeﬃ   cients were used to assess 
whether maternal 25(OH)D concentrations in diﬀ erent 
trimesters were associated with each other, and also 
whether they were associated with oﬀ spring 25(OH)D 
concen trations.
We used linear regression to explore associations 
between maternal 25(OH)D concentration in pregnancy 
and oﬀ spring BMC: model A was minimally adjusted 
and included maternal age and oﬀ spring age and sex 
(we do not report results of completely unadjusted asso-
ciations because they were not notably diﬀ erent from 
these); model B was the main confounder-adjusted 
model, and was model A plus adjustment for maternal 
education, parity, ethnic origin, smoking during 
pregnancy, and body-mass index before pregnancy; 
model C was model B plus adjustment for potential 
mediation by oﬀ spring growth and size (birthweight, 
gestational age, and oﬀ spring height, lean mass, and fat 
mass); and model D was model B plus adjustment for 
potential mediation by oﬀ spring 25(OH)D concen-
trations (appendix p 3). Mediation was explored by 
comparison of the confounder-adjusted models with 
and without the addition of potential mediators. 
Diﬀ erences in associations between female and male 
oﬀ spring were tested in all models by the inclusion of 
interaction terms for sex. Non-linearity was tested with 
quadratic and cubic polynomials and explored by 
examination of associations between adult categories of 
25(OH)D concentrations (suﬃ  cient, 50·00 nmol/L or 
higher; insuﬃ  cient, 49·99–27·50 nmol/L; deﬁ cient, 
lower than 27·50 nmol/L), which are based on cutoﬀ  
points that have been most commonly used in previous 
studies of pregnant women.5
An important source of 25(OH)D is synthesis in the 
skin in response to exposure to ultraviolet B, and 
25(OH)D concentrations show a strong sinusoidal 
pattern with date of blood collection—ie, concentrations 
are lower in participants whose samples were collected 
during winter months than are those in participants 
whose samples were collected during summer months 
(appendix pp 1–3). This pattern was modelled with a 
sine–cosine regression model. We derived a variable 
that adjusted each woman’s total 25(OH)D concen-
trations to the date corresponding to her trimester 
midpoint (ﬁ rst trimester, 6 weeks; second trimester, 
20 weeks; third trimester, 34 weeks). To investigate 
associations between timing of maternal 25(OH)D 
concentration and oﬀ  spring BMC, we stratiﬁ ed the 
participants by trimester. We assessed whether there 
See Online for appendix
Figure 1: Trial proﬁ le
ALSPAC= Avon Longitudinal Study of Parents and Children. 25(OH)D=25-hydroxyvitamin D. DXA=dual-energy 
x-ray absorptiometry.
14 541 mothers recruited to ALSPAC 
 pregnancy cohort12, 13
924 excluded
 69 unknown outcomes
 604 no livebirth
 1 livebirth from a twin pregnancy
 189 multiple pregnancies
 61 oﬀspring died within 12 months
13 617 mother-oﬀspring pairs with live 
 singleton infants surviving to 12 months
9657 excluded
 5903 no pregnancy 25(OH)D result
 3549 oﬀspring did not attend clinic
 205 no oﬀspring DXA scan
764 spinal curvature on DXA
3960 mother-oﬀspring pairs eligible for this 
 study
3960 oﬀspring assessed for 
 total-body bone outcomes 
3196 oﬀspring assessed for spinal 
 bone outcomes 
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was statistical evidence for a diﬀ erence in the asso-
ciations between trimesters by exam ining the asso-
ciation in the whole sampleand including an inter action 
term between trimester of assessment of maternal 
maternal 25(OH)D concentrations.
We generated predicted third-trimester 25(OH)D con-
cen trations for all women, by adjustment of maternal 
25(OH)D concentration to 34 weeks’ gestation, irre-
spective of when the blood samples were taken. A ﬁ nal 
variable was generated that adjusted for seasonality, to 
obtain a marker of habitual 25(OH)D concentration, by 
use of the residuals from the sine–cosine regression 
models. Similar trigonometric models were ﬁ tted to the 
oﬀ spring data to adjust for season, as previously 
described (appendix pp 1–3).9
Additionally to the main analyses of the relations 
between maternal pregnancy 25(OH)D concentrations 
and oﬀ spring BMC and other bone outcomes, we 
investigated whether the previously resported association 
between estimated third-trimester exposure to ultraviolet 
B and oﬀ spring BMC16 was present in this study sample 
and whether it was mediated by maternal third-trimester 
25(OH)D concentration.
To increase eﬃ  ciency and keep selection bias to a 
minimum, we used multivariate multiple imputation 
(Stata, version 11 MP2) to impute missing values of 
covariables for eligible participants, according to the 
method described by Royston.17 The amount of missing 
data varied from 0 to 16% for any single variable. 72% of 
had complete data for TBLH BMC and 72% had complete 
data for spinal BMC (appendix p 4). The distributions of 
the variables with missing data did not diﬀ er substantially 
between participants with observed data and those with 
imputed data (appendix p 4). The associations between 
maternal 25(OH)D concentrations and oﬀ spring BMC 
and other bone outcomes obtained from analyses in 
those with complete data on all covariables did not diﬀ er 
Figure 2: Mean diﬀ erences in oﬀ spring bone-mineral content in relation to maternal 25(OH)D concentrations 
in pregnancy, by trimester
(A) Oﬀ spring total body bone-mineral content (total body less head measured; n=3960). 
(B) Oﬀ spring spine bone-mineral content (n=3196). The p values test whether the association between 
maternal 25(OH)D concentration and oﬀ spring BMC diﬀ ers by trimester of measurement. Model A adjusted for 
maternal age and oﬀ spring age and sex. Model B, the main confounder-adjusted model, was model A plus 
adjustment for maternal education, ethnic origin, parity, smoking in pregnancy, and body-mass index before 
pregnancy. Model C was model B plus adjustment for potential mediation by birthweight, gestational age, and 
oﬀ spring height, lean mass, and fat mass. Model D was model B plus adjustment for potential mediation by 
oﬀ spring 25(OH)D concentrations. Values missing for covariables were calculated by multivariate multiple 
imputation. 25(OH)D=25-hydroxyvitamin D. Predicted 3rd=all women with 25(OH)D concentrations adjusted 
to 34 weeks’ gestation.
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Model A Model B Model C Model D
eUVB (n=3960) 25(OH)D
T1 (n=1035) T2 (n=879) T3 (n=2046) Cumulative T3 
(n=2046)*
Predicted T3 
(n=3960)
Maternal SA 
(n=3960)
Oﬀ spring 
(n=3960)
Oﬀ spring SA 
(n=3960)
eUVB 1·00 ·· ·· ·· ·· ·· ·· ·· ··
25(OH)D
T1 –0·01 1·00 ·· ·· ·· ·· ·· ·· ··
T2 –0·38† NA 1·00 ·· ·· ·· ·· ·· ··
T3 0·35† NA NA 1·00 ·· ·· ·· ·· ··
Cumulative T3* 0·37† NA NA 0·99† 1·00 ·· ·· ·· ··
Predicted T3 0·07† 0·91† 0·93† 0·99† 0·99† 1·00 ·· ·· ··
Maternal SA 0·01 0·86† 0·84† 0·84† 0·80† 0·85† 1·00 ·· ··
Oﬀ spring –0·08† 0·01 0·22† 0·16† 0·16† 0·17† 0·14† 1·00 ··
Oﬀ spring SA –0·01 0·12† 0·15† 0·15† 0·14† 0·14† 0·15† 0·86† 1·00
eUVB=estimated exposure to ultraviolet B. 25(OH)D=25-hydroxyvitamin D. T1=ﬁ rst trimester. T2=second trimester. T3=third trimester. SA=seasonally adjusted. NA=not 
available (women only had a measure in one trimester). *Cumulative 25(OH)D exposure over ﬁ nal 10 weeks of T3 for women with a sample taken in third trimester. †p<0·05.
Table 1: Correlations between maternal 25(OH)D concentrations in pregnancy, exposure to ultraviolet B in the third trimester, and oﬀ spring 
25(OH)D concentrations
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substantially from the same associations obtained from 
analyses in the multivariable multiple-imputed datasets 
(appendix p 5).
Roles of the funding sources
The sponsors of the study had no role in study design, 
data collection, data analysis, data interpretation, or 
writing of the report. The corresponding author had 
full access to all the data in the study and had ﬁ nal 
responsibility for the decision to submit for publication.
Results
3960 eligible mother-and-oﬀ spring pairs were assessed 
in this study (ﬁ gure 1). The mean age of oﬀ spring at the 
time of BMC assessment was 9·9 years. Maternal 
25(OH)D concentrations were measured in the ﬁ rst 
trimester in 1035 (26%) women, in the second tri-
mester in 879 (22%), and in the third trimester in 
2046 (52%). The median 25(OH)D concentration was 
lowest in the ﬁ rst trimester (55·1 nmol/L, IQR 
40·7–74·1), intermediate in the second trimester 
(60·1 nmol/L, 41·4–83·4), and highest in the third 
trimester (67·4 nmol/L, 46·8–93·0). For the predicted 
third-trimester 25(OH)D concentrations, we estimated 
that 2644 (67%) would be suﬃ  cient, 1096 (28%) insuf-
ﬁ cient, and 220 (6%) deﬁ cient.
Seasonally adjusted and unadjusted 25(OH)D levels 
correlated strongly. Estimated exposure to ultraviolet B 
in the third-trimester was marginally positively correl-
ated with third-trimester 25(OH)D concentration, in-
versely correlated that in the second trimester, and not 
associated with that in the ﬁ rst trimester (table 1). 
Maternal 25(OH)D concentration in pregnancy showed 
a weak association with oﬀ spring 25(OH)D concen-
tration, whereas exposure to ultraviolet B showed no 
association (table 1).
Compared with eligible participants, the mother-and-
oﬀ spring pairs who were excluded because of missing 
maternal 25(OH)D or oﬀ spring BMC values had mothers 
who were younger, had lower educational attainment, 
were more likely to be of non-white ethnic origin, to have 
already had at least two previous pregnancies, and to 
Model A* Model B† Model C‡ Model D§
Diﬀ erence in BMC 
per 10·0 nmol/L 
25(OH)D (g)
p value Diﬀ erence in BMC 
per 10·0 nmol/L 
25(OH)D (g)
p value Diﬀ erence in BMC 
per 10·0 nmol/L 
25(OH)D (g)
p value Diﬀ erence in BMC 
per 10·0 nmol/L 
25(OH)D (g)
p value
Predicted third-trimester maternal 25(OH)D concentration
TBLH BMC (n=3960) –0·47 (–2·16 to 1·23) 0·6 –0·03 (–1·71 to 1·65) 0·97 0·13 (–0·62 to 0·87) 0·7 0·01 (–1·68 to 1·71) 0·99
Spine BMC (n=3196) 0·01 (–0·15 to 0·17) 0·9 0·04 (–0·12 to 0·21) 0·6 0·06 (–0·03 to 0·16) 0·2 0·04 (–0·12 to 0·21) 0·6
Seasonally adjusted predicted-third trimester maternal 25(OH)D concentration
TBLH BMC (n=3960) –0·51 (–2·43 to 1·40) 0·6 –0·01 (–1·93 to 1·89) 0·99 –0·11 (–0·94 to 0·73) 0·8 0·04 (–1·88 to 1·97) 0·96
Spine BMC (n=3196) 0·02 (–0·17 to 0·21) 0·8 0·06 (–0·13 to 0·24) 0·6 0·07 (–0·04 to 0·17) 0·2 0·06 (–0·13 to 0·24) 0·6
Data are mean diﬀ erences (95% CI). Values missing for covariables were calculated by multivariate multiple imputation. BMC=bone-mineral content. 25(OH)D=25-
hydroxyvitamin-D. TBLH=total body less head. *Adjusted for maternal age and oﬀ spring age and sex. †Main confounder-adjusted model; model A plus adjustment for 
maternal education, ethnic origin, parity, smoking in pregnancy, and body-mass index before pregnancy. ‡Model B plus adjustment for potential mediation by birthweight, 
gestational age, and oﬀ spring height, lean mass, and fat mass. §Model B plus adjustment for potential mediation by oﬀ spring 25(OH)D concentrations.
Table 2: Multivariable associations between predicted maternal third-trimester 25(OH)D concentrations and oﬀ spring BMC
Model A* Model B† Model C‡ Model D§
Diﬀ erence in BMC per 
25(OH)D category (g)
p value¶ Diﬀ erence in BMC per 
25(OH)D category (g)
p value¶ Diﬀ erence in BMC per 
25(OH)D category (g)
p value¶ Diﬀ erence in BMC per 
25(OH)D category (g)
p value¶
TBLH BMC (n=3960) 0·5 0·4 0·7 0·4
Suﬃ  cient (≥50·00 nmol/L; n=2644) 0 (reference) 0 (reference) 0 (reference) 0 (reference)
Insuﬃ  cient (49·99–27·50 nmol/L; n=1096) –0·9 (–13·4 to 11·5) –2·1 (–14·4 to 10·2) 1·0 (–4·5 to 6·6) –2·4 (–14·8 to 10·0)
Deﬁ cient (<27·50 nmol/L; n=220) –10·0 (–34·3 to 14·4) –11·7 (–35·8 to 12·5) 1·0 (–9·9 to 11·9) –12·2 (–36·4 to 12·1)
Spine BMC (n=3196) 0·5 0·4 0·7 0·4
Suﬃ  cient (≥50·00 nmol/L; n=2122) 0 (reference) 0 (reference) 0 (reference) 0 (reference)
Insuﬃ  cient (49·99–27·50 nmol/L; n=884) –0·1 (–1·3 to 1·1) –0·3 (–1·5 to 0·9) –0·1 (–0·8 to 0·6) –0·3 (–1·5 to 0·9)
Deﬁ cient (<27·50 nmol/L; n=190) –0·9 (–3·2 to 1·3) –0·9 (–3·2 to 1·3) –0·3 (–1·6 to 1·1) –0·9 (–3·2 to 1·3)
Data are mean diﬀ erences (95% CI). Values missing for covariables were calculated by multivariate multiple imputation. BMC=bone-mineral content. 25(OH)D=25–hydroxyvitamin-D. TBLH=total body less head. 
*Adjusted for maternal age and oﬀ spring age and sex. †Main confounder adjusted model; model A plus adjustment for maternal education, ethnic origin, parity, smoking in pregnancy, and body-mass index before 
pregnancy. ‡Model B plus adjustment for potential mediation by birthweight, gestational age and oﬀ spring height, lean mass, and fat mass. §Model B plus adjustment for potential mediation by oﬀ spring 
25(OH)D concentrations. ¶Testing for linear trend across the 25(OH)D categories; there was no evidence for non-linear associations based on cubic and higher-order polynomials (all p>0·2).
Table 3: Multivariable associations between predicted third-trimester maternal 25(OH)D categories and oﬀ spring BMC
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have smoked during pregnancy (appendix p 6). Maternal 
25(OH)D in the third trimester and oﬀ spring gestational 
age, birthweight, spine BMD, age at outcome measure, 
and 25(OH)D concentration diﬀ ered between eligible 
and excluded maternal-oﬀ spring pairs, but the median 
values were similar (appendix p 7). These small p values 
have arisen because of the large sample size in this study. 
The diﬀ erences are unlikely to be due to chance but are 
not clinically important.
A linear association was noted between maternal age 
and maternal 25(OH)D concentration, such that older 
age was associated with higher 25(OH)D concentrations 
in the second and third trimesters than was younger 
age, and greater parity was associated with higher 
25(OH)D concentration in the third tri mester (appen-
dix p 8). Non-white mothers had lower 25(OH)D levels, 
particularly from the second trimester onwards, than 
white mothers, and those who smoked during preg-
nancy had lower 25(OH)D across all trimesters than 
non-smokers. Maternal body-mass index before preg-
nancy and education were not associated with 25(OH)D 
concentrations in pregnancy.
Maternal 25(OH)D concentration, in any trimester of 
pregnancy, was not associated with oﬀ spring BMC. These 
null associations were similar in all multivariable models 
and when 25(OH)D was seasonally adjusted (ﬁ gure 2, 
table 2). Mean oﬀ spring BMC was similar in the oﬀ spring 
of mothers with insuﬃ  cient and deﬁ cient levels of 
25(OH)D in the third trimester, compared with values for 
oﬀ spring of mothers with suﬃ  cient levels (table 3). 
Sensitivity analyses in which the threshold for suﬃ  cient 
25(OH)D concentration was changed to 75·0 nmol/L also 
showed no association. Tests of non-linear relationships 
across the maternal 25(OH)D suﬃ  ciency categories and 
higher-order polynomials were null (table 3).
No maternal 25(OH)D measurement in any trimester, 
with or without seasonal adjustment, was associated with 
any oﬀ spring bone outcomes in any of the multivariable 
models (appendix pp 9–13). Mean bone outcomes were 
similar in oﬀ spring of mothers with deﬁ cient or 
insuﬃ  cient 25(OH)D concentrations to those in mothers 
with suﬃ  cient concentrations (appendix pp 10–11). A 
measure of cumulative 25(OH)D in the last 10 weeks of 
the 3rd trimester similarly had null associations with all 
outcomes (results available from authors on request).
Data suggested that associations between maternal 
25(OH)D concentra tions in the second and third tri-
mesters and oﬀ spring BMC diﬀ ered for girls and boys. 
In the confounder-adjusted models, higher maternal 
25(OH)D con centrations were associated with BMC in 
girls, but with higher BMC in boys (ﬁ gure 3). This diﬀ er-
ence between the sexes, however, was com pletely explained 
by mediation by oﬀ spring charac teristics. Speciﬁ cally, this 
interaction was mediated by a diﬀ erence in the relation 
between maternal 25(OH)D concentration in pregnancy 
and oﬀ spring height and lean mass for girls and boys. The 
diﬀ erence in BMC between the sexes disappeared with 
adjustment for either of these features alone. Similar 
patterns of diﬀ erences between boys and girls were also 
seen with TBLH adjusted bone area, but there were no 
other such interactions with maternal 25(OH)D concen-
trations for oﬀ spring bone outcomes in any models.
Estimated exposure to ultraviolet B in the third 
trimester was positively associated with TBLH BMC 
(table 4). When we adjusted for oﬀ spring age at the time 
of bone measurements, however, these associations 
Figure 3: Mean diﬀ erences in oﬀ spring bone-mineral content in relation to maternal 25(OH)D concentrations 
in pregnancy, by trimester and sex of oﬀ spring
(A) Oﬀ spring total body bone-mineral content (total body less head measured; n=3960). (B) Oﬀ spring spine 
bone-mineral content (n=3196). Model A adjusted for maternal age and oﬀ spring age and sex. Model B, the main 
confounder-adjusted model was model A plus adjustment for maternal education, ethnic origin, parity, smoking 
in pregnancy, and body-mass index before pregnancy. Model C was model B plus adjustment for potential 
mediation by birthweight, gestational age, and oﬀ spring height, lean mass, and fat mass. Model D was model B 
plus adjustment for potential mediation by oﬀ spring 25(OH)D. Values missing for covariables were calculated by 
multivariate multiple imputation. 25(OH)D=25-hydroxyvitamin D. Predicted 3rd=all women with 25(OH)D 
concentrations adjusted to 34 weeks’ gestation.
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of oﬀ spring at DXA
eUVB adjusted for age of 
oﬀ spring at DXA and 
maternal 25(OH)D
Diﬀ erence 
per SD (g)
p value Diﬀ erence 
per SD (g)
p value Diﬀ erence 
per SD (g)
p value
TBLH BMC 
(n=3960)
13·8 
(8·26 to 19·34)
<0·0001 0·95 
(–4·71 to 6·61)
0·7 1·04 
(–4·65 to 6·72)
0·7
Spine BMC 
(n=3196)
0·33 
(–0·20 to 0·86)
0·2 –0·64 
(–1·18 to –0·10)
0·02 –0·66 
(–1·20 to –0·11)
0·02
Data are mean diﬀ erences (95% CI). eUVB=estimated exposure to ultraviolet B. DXA=dual x-ray absorptiometry. 
25(OH)D=25-hydroxyvitamin D. TBLH=total body less head. BMC=bone-mineral content.
Table 4: Multivariable associations between maternal estimated exposure to ultraviolet B in the third 
trimester and oﬀ spring BMC
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became null. Associations between estimated exposure 
to ultraviolet B and all other bone outcomes were also 
null after age was taken into account (appendix p 14). 
Reassessment of the previously reported sample16 showed 
that adjustment for oﬀ spring age completely attenuated 
all the associations to null. This removal of the association 
with adjustment for age occurred because estimated 
third-trimester exposure to ultraviolet B in the ALSPAC 
cohort is associated with oﬀ spring age at the time of 
BMC assessment (mean diﬀ erence in age 1·2 months 
per 1 SD increase in estimated exposure to ultraviolet B 
(95% CI 1·1–1·3, p<0·0001).
Discussion
In this large prospective study, we found no evidence that 
maternal 25(OH)D concentration in any trimester of 
pregnancy was associated with oﬀ spring BMC or other 
bone outcomes at a mean oﬀ spring age of 9·9 years. The 
positive association we reported previously between 
estimated ambient exposure to ultraviolet B in the third 
trimester of pregnancy and oﬀ spring BMC and BMD at 
age 9·9 years16 seems to be fully explained by oﬀ spring age 
at the time of DXA. Ordinarily, we would not expect 
diﬀ erences between children’s ages to be associated with 
the mothers’ potential exposure to sunlight towards the 
end of pregnancy. For this reason, in our previous report 
we did not judge the children’s ages at the time of BMC 
assessment to be a confounder and, therefore, did not 
control for this feature. We now realise that oﬀ spring age 
in this study is associated with mothers’ estimated 
exposure to ultraviolet B in the third trimester, owing to a 
quirk in the dates when oﬀ spring had their BMC assessed. 
Those who had been born in the late summer or early 
autumn (and, therefore, whose mothers were in their 
third-trimester in the summer months) were more likely 
to undergo DXA scanning at older average age than 
children born at other times of year. Childhood age is 
positively associated with BMC,8 which is conﬁ rmed by 
our results from this study: each year of age was associated 
with 132·0 g (95% CI 115·5–148·8) greater total BMC. As a 
result of the strong associations between oﬀ spring age and 
maternal estimated exposure to ultraviolet B in the third 
trimester and oﬀ spring BMC, our ﬁ ndings show that age 
confounds the previously reported associations between 
these two features. Thus, our ﬁ ndings show that there is 
no strong evidence that maternal 25(OH)D concentrations 
in pregnancy are related to childhood BMC.
An important strength of this study is its large sample 
size, as previous studies included fewer than 200 mother-
and-oﬀ spring pairs (panel). We were able to adjust for 
several potential confounding factors and to compare 
associations with maternal 25(OH)D concentrations in 
diﬀ erent trimesters. Some previous studies have only 
reported associations for logged maternal 25(OH)D 
concentration;4,8 our results were essentially the same 
after log trans formation (results available from authors 
on request).
As with other prospective studies, there was loss to 
follow-up and not all mothers had samples available for 
assessment of 25(OH)D levels. Children who were 
Panel: Research in context
Systematic review
We systematically searched PubMed with the term “pregn* [AND] (vitamin D [OR] 
25(OH)D) [AND] (bone mineral content [OR] BMC [OR] bone density [OR] bone mineral 
density [OR] BMD)”, and also identiﬁ ed relevant articles from the reference lists of any 
retrieved papers. We only considered studies in human beings. We identiﬁ ed four reports 
from three independent cohort studies that had assessed the association between 
pregnancy 25(OH)D concentration with oﬀ spring BMC. In the ﬁ rst study of 
50 mother-and-oﬀ spring pairs, lower concentrations of maternal 25(OH)D in pregnancy 
were associated with higher whole-body BMC in oﬀ spring at age 2 weeks (mean diﬀ erence 
–0·139 g per 1 nmol/L increase in 25(OH)D, p<0·05).7 In a later and larger study of 
198 mother-and-oﬀ spring pairs, where the mean age of oﬀ spring was 9 years, serum 
25(OH)D concentration in the third trimester of pregnancy was weakly positively associated 
with whole-body BMC (Pearson’s correlation coeﬃ  cient r=0·21, p=0·0088) and lumbar 
spinal BMC (r=0·17, p=0·03).4 Lastly, in a study of 60–125 mother-and-oﬀ spring pairs 
(numbers varied for diﬀ erent outcomes at diﬀ erent ages), maternal 25(OH)D concentration 
in pregnancy above the median was positively associated with oﬀ spring tibial BMC at birth 
(mean diﬀ erence 0·047 g/cm, 95% CI 0·011–0·082) compared with maternal 
25(OH)D concentrations below the median.18 However, postnatally, the age-related 
increase in tibial BMC was greater in those whose mothers had 25(OH)D concentrations 
below the median than in those whose mothers had values higher than the median (by 
0·062 g/cm, SE 0·029). By 14 months the BMC no longer diﬀ ered between the lower and 
higher maternal 25(OH)D groups (mean value around 0·44 g/cm, obtained by use of a ruler 
on the ﬁ gure provided in the report).8 Despite inconsistencies, these results have been 
interpreted as evidence that variation in maternal vitamin D status in pregnancy is causally 
related to oﬀ spring bone health via intrauterine mechanisms. In particular, the ﬁ ndings of 
the second study4 have been frequently cited as evidence for the importance of vitamin D 
supplementation in pregnancy. If vitamin D status in pregnancy is causally related to 
oﬀ spring bone outcomes, the issue is important for public health, as high proportions of 
otherwise healthy pregnant women are reported to be deﬁ cient of vitamin D or have 
insuﬃ  cient vitamin D. Although correlation in the second study was weak, it was linear 
across the whole distribution of maternal 25(OH)D concentrations,4 which suggests that if 
the association is causal, increases in pregnancy vitamin D status in all women could lead to 
important population-level improvements in BMC.
Interpretation
We did a large observational study and found no evidence of any association between 
maternal 25(OH)D concentrations in pregnancy and oﬀ spring total-body (less head) or 
spinal BMC. The third trimester is thought to be most relevant to oﬀ spring BMC, but our 
ﬁ ndings did not diﬀ er when assessed by timing of 25(OH)D measurement. Null associations 
were found in all statistical models and in a series of sensitivity analyses. The pooling of 
results from previous studies and our study was not feasible because of the diﬀ erent ways in 
which the association has been modelled. Nevertheless, our study was more than ten times 
larger than previous studies combined. In view of the diﬀ ering directions of previous results 
(positive, null, and negative associations) and the sample sizes relative to that in our study, 
if we were able to pool all the previous study results, including ours, the pooled results 
would be consistent with those from our study alone (presented here) and would not be 
notably more precisely estimated (conﬁ rmed by a simulation analysis, unpublished). Thus, 
our results challenge the assertion that vitamin D supplementation should be provided to 
pregnant women to prevent low BMC in oﬀ spring in later life.
25(OH)D=25-hydroxyvitamin D. BMC=bone-mineral content.
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excluded mainly had mothers who were younger, less 
well educated, non-white ethnic origin, and higher parity 
and were likely to smoke in pregnancy than did included 
children. Maternal 25(OH)D concentrations and oﬀ -
spring BMC and most other bone outcomes, however, 
were similar for included and excluded oﬀ spring. Around 
two-thirds (67%) of women in this study had suﬃ  cient 
concentrations of 25(OH)D in pregnancy. In populations 
with lower maternal 25(OH)D concentrations, oﬀ spring 
BMC might also be reduced. Nevertheless, we found no 
diﬀ erence in mean BMC between oﬀ spring of mothers 
who had suﬃ  cient or deﬁ cient 25(OH)D concentrations 
in pregnancy. A study that reported a positive association 
between maternal 25(OH)D and oﬀ spring BMC found a 
linear dose-response relation across the whole 25(OH)D 
dis tribution.4 Furthermore, the deﬁ nitions of 25(OH)D 
insuﬃ  ciency and deﬁ ciency are strongly debated, 
particularly in pregnancy.18
In one study of 50 mother-and-oﬀ spring pairs, lower 
concentrations of maternal 25(OH)D were associated with 
higher infant whole-body BMC at age 2 weeks (panel).7 In 
a later study of 198 mother-and-oﬀ spring pairs, a linear 
dose-response association was seen between lower mater-
nal 25(OH)D concentrations in the third trimester and 
lower whole-body and lumbar-spine BMC (panel).4 In a 
third study, a positive association was shown between 
maternal 25(OH)D levels in pregnancy above the median 
value and oﬀ spring tibial BMC at birth (panel).19 Of note, 
though, tibial BMC increased at a greater rate postnatally 
in the oﬀ spring of mothers with 25(OH)D concentrations 
below the median (by 0·062 g/cm, SE 0·029) than did 
BMC in those whose mothers had 25(OH)D levels above 
the median; by age 14 months, the BMC values were 
identical in the two subgroups.8
The inconsistency in ﬁ ndings might reﬂ ect chance 
variation around a null value in small studies, as is 
supported by the null ﬁ ndings in our much larger study. 
The ages at which outcomes were assessed diﬀ ered 
between studies, which might also have contributed to 
inconsistencies. That maternal 25(OH)D concentrations 
in pregnancy would aﬀ ect BMC at birth and in early 
infancy seems more plausible than later in childhood. 
Maternal 25(OH)D concentration in pregnancy is posi-
tively cor related with concentrations in cord blood,20 and 
maternal 25(OH)D concentration in the third trimester 
has been suggested to aﬀ ect bone mineral isation in 
utero.4,10,11 A positive association has been shown between 
maternal 25(OH)D concentration and BMC at birth,19 but 
is not sustained.8 By contrast, a positive association 
between maternal 25(OH)D concentration in pregnancy 
with oﬀ spring BMC was found by Javaid and colleagues 
in children assessed at age 9–10 years.4
Javaid and colleagues’ study and our study have many 
features in common: both involved cohorts from the south 
of England, largely of white European origin; levels of 
maternal 25(OH)D were similar; both measured out comes 
when oﬀ spring were aged 9–10 years; both used DXA to 
assess BMC; and both adjusted for age as well as a range of 
potential confounding characteristics. The studies diﬀ er 
for timing of 25(OH)D measurement: in Javaid and 
colleagues’ study all measurements were made in the third 
trimester, whereas we included women with measure-
ments from diﬀ erent trimesters. Never theless, our sample 
of 2046 women with third-trimester values is more than 
ten times larger than that of Javaid and colleagues (n=198), 
and we found no evidence of association in this subgroup.
International guidelines have cited the Javaid and 
colleagues’ ﬁ ndings as evidence for the importance of 
vitamin D supplementation in pregnant women. The 
magnitude of association in that study (r=0·17–0·21), 
however, was weak and unlikely to be clinically important 
for individuals. Assessment of our substantially larger 
sample suggested no association. We believe, therefore, 
that there is no strong evidence that pregnant women 
should receive vitamin D supplementation to prevent low 
BMC in their oﬀ spring, although we cannot comment on 
other possible eﬀ ects of vitamin D in pregnant women. 
Furthermore, we have previously shown that oﬀ spring 
25(OH)D concentrations at a mean age of 9·9 years are 
prospectively associated with BMC and other bone 
outcomes assessed at a mean age of 15·5 years in this 
cohort.9 Our results should not be interpreted as 
suggesting that individual 25(OH)D concentrations are 
not an important determinants of bone health.
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